19th Annual Conference of BHIVA Presentations - Wednesday 17th April 2013

Please click on an icon to download a file. You can view and download presentations from other days of the conference by clicking on the links below:

 

BHIVA Review Session

Five papers to change clinical practice
Professor Andrew Lever, University of Cambridge

BHIVA Lunchtime Workshop 1 - Difficult pharmacology case presentations

Dangerous liaisons
Dr Gurmit Jagit Singh, Chelsea and Westminster Hospital, London

What's the craic?
Dr Leann Johnson, North Manchester General Hospital

To treat or not to treat?: a toxicity dilemma
Dr Keerti Gedela, Chelsea and Westminster Hospital, London

BHIVA Lunchtime Workshop 2

TB /HIV co-infection case presentations
Dr Marc Lipman, Royal Free Hospital, London

BHIVA Keynote Lecture

Viral resistance: a look into the crystal ball
Dr Charles Boucher, University Medical Center Utrecht, Netherlands

Oral Research Presentations: Session 1 - Behaviour, attitudes and testing

Abstract O1: Is primary care prescribing for people with HIV safe? A review of practice in an inner London setting
Dr Rosie Wellesley, Barts and The London School of Medicine and Dentistry

Abstract O2: Increasing opportunities for HIV diagnosis in primary care: a borough-wide evaluation of HIV testing and pre-diagnosis care in general practice
Dr Alice Whittle, City and Hackney Public Health Department, London

Abstract O3: CD4 point of care testing improves patient satisfaction and reduces recalls to clinic
Dr Clifford Jones, Imperial College Healthcare NHS Trust, London

Abstract O4: Prevalence of, and risk factors for, human immunodeficiency virus, hepatitis B and hepatitis C infections among men who inject image- and performance-enhancing drugs in England and Wales
Dr Vivian Hope, Health Protection Agency, London

Abstract O5: Psychological and physical symptoms and sexual behaviour among HIV-diagnosed men who have sex with men (MSM) in the UK
Dr Fiona Lampe, University College London

BHIVA Invited Lectures

Generics: how should we use them?
Dr Mark Nelson, Chelsea and Westminster Hospital, London

BHIVA is grateful for an educational grant in support of this lecture from Boehringer Ingelheim

Towards a cure
Dr Romas Geleziunas, Gilead Sciences Inc, USA